MedTrace Logo

Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

NCT02833246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2018-11-19

No results posted yet for this study

Summary

This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

Conditions

  • Sarcoma
  • Lung
  • Solid Tumor Gastrointestinal

Interventions

OTHER

SMS/MMS text messaging

text messaging reminders on oral chemotherapy medication adherence

OTHER

usual care

Sponsors & Collaborators

Principal Investigators

  • Thomas Atkinson, PhD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-28
Primary Completion
2018-11-14
Completion
2018-11-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02833246 on ClinicalTrials.gov